-
Fluo-4 AM Calcium Assay Kit for Mechanobiology
2026-09-29
Connect scaffold architecture to live-cell Ca2+ dynamics with a 488 nm-compatible, no-wash workflow. The Fluo-4 AM Calcium Assay Kit also supports scalable GPCR inhibitor screening and GPCR agonist screening while leaving cells available for phenotype and matrix analysis.
-
CUDC-907: Practical PI3K/HDAC Assay Guide
2026-09-29
This guide translates the CUDC-907 product dossier into a controlled workflow for studying coordinated PI3K/AKT signaling pathway inhibition, histone deacetylase activity, cell-cycle effects, and apoptosis in cancer cell models. It is intended for scientific in vitro research only and should not be used for diagnostic, therapeutic, or clinical applications.
-
Annexin V Beyond Apoptosis: Reading PS Surfaces
2026-09-28
Annexin V is a calcium-dependent phosphatidylserine binding protein, but its signal is best understood as a readout of accessible membrane phosphatidylserine—not apoptosis alone. This article connects cell-death assays to endothelial coagulation research and explains how that distinction can sharpen experimental interpretation.
-
Ibrutinib (PCI-32765): BTK Research Beyond the Assay
2026-09-27
Explore how Ibrutinib (PCI-32765) can support rigorous BTK and B-cell research, from pathway interrogation to translational model design—with clear boundaries between mechanistic evidence and cross-domain analogy.
-
DrPISA Extends Thermal Proteomics to Aggregated Proteins
2026-09-26
DrPISA combines reverse PISA with a deep eutectic solvent that improves recovery and digestion of heat-aggregated proteins, extending thermal target profiling beyond the soluble fraction. The study reports greater protein identification, detection of subtle stability responses, and a six-temperature workflow that reduces reagent use and mass-spectrometry time.
-
Sisomicin: From 30S Mechanism to Translational Evidence
2026-09-26
Sisomicin links a defined 30S ribosomal mechanism to a historically broad in vitro activity profile. This article examines what clinical-isolate data can—and cannot—tell translational teams, and offers practical guidance for designing interpretable susceptibility experiments and framing resistance findings.
-
CA800-PR Suppresses Progesterone Signaling in Breast Cancer
2026-09-25
The study presents CA800-PR, a tumor-targeted near-infrared heptamethine cyanine dye that induces Golgi fragmentation, selectively reduces progesterone receptor protein, and promotes apoptosis in hormone receptor-positive breast cancer models. Its findings suggest a distinct therapeutic strategy that combines imaging capability with direct antitumor effects, while requiring further validation beyond the reported cell and xenograft models.
-
Clathrin-Mediated Entry of Grass Carp Reovirus
2026-09-25
Wang et al. used pharmacological inhibition, electron microscopy, and quantitative PCR to investigate how genotype III grass carp reovirus enters cultured grass carp kidney cells. Their results support a clathrin- and dynamin-dependent entry route, with evidence for a role of endosomal acidification, while the lack of inhibition by Latrunculin B limits the case for an essential actin-polymerization step under the conditions tested.
-
Collagen VI Scaffolds Improve iPSC Islet Organoids
2026-09-24
Zhu and colleagues report that decellularized amniotic membrane (dAM) matrices support the development and function of iPSC-derived islet organoids, and identify collagen VI as an important component of this niche. Their findings connect matrix composition with organoid viability, glucose-responsive function, and engraftment in diabetic mice, while highlighting the need to validate scaffold performance across models and manufacturing conditions.
-
FCCP and Mitochondrial-to-Peroxisome Biology
2026-09-24
FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) can reveal how mitochondrial energy disruption affects cellular readouts, but it is not a direct test of peroxisome biogenesis. This article connects FCCP assay design to new findings on MARCH5-dependent PEX3 vesicle formation and explains how to separate energetic effects from organelle-assembly mechanisms.
-
Cefoperazone Sodium Salt: Assay Workflows
2026-09-23
Build more reproducible antimicrobial assays with Cefoperazone sodium salt, from fresh stock preparation through MIC/MBC testing and resistance profiling. The workflow also shows how to interpret cefoperazone in gram-negative panels and biliary tract infection research without overstating comparator data.
-
Bafilomycin A1: Reading V-ATPase Assay Results
2026-09-23
Bafilomycin A1 is more than a potent V-ATPase inhibitor: it is a diagnostic tool for separating proton dependence from pathway sensitivity. This article analyzes a grass carp reovirus study and translates its nuanced negative result into stronger experimental design.
-
SM-102 for mRNA LNP Workflow Optimization
2026-09-22
SM-102 supports reproducible lipid nanoparticle workflows for mRNA vaccine development and localized therapeutic delivery. This guide translates a recent bladder cancer study into practical formulation, assay, and troubleshooting decisions while keeping product handling and translational limitations explicit.
-
Naringin, VEGFC, and Hepatic Fibrosis
2026-09-21
This 2026 Phytomedicine study identifies a hepatocyte VEGFC–macrophage regulatory axis that links metabolic liver injury to inflammatory recruitment and fibrotic progression. By combining pharmacological inhibition with hepatocyte-specific Vegfc deletion, the authors show how naringin and SAR131675 reduce VEGFC-dependent macrophage responses and provide a mechanistic framework for studying VEGFR-3 signaling in NASH-associated fibrosis.
-
Reparixin for Reliable CXCR1/2 Assays
2026-09-21
Learn how Reparixin (SKU A3752) can improve mechanistic interpretation in neutrophil migration, inflammation, proliferation, and cytotoxicity workflows. This scenario-based guide covers solvent compatibility, assay controls, animal-model translation, data interpretation, and practical product selection.